95 3.1. Comment expliquer ces deux cas discordants ?, p.96 ,
Estimates of cancer incidence and mortality in Europe in 2008, European Journal of Cancer, vol.46, issue.4, pp.765-81, 2010. ,
DOI : 10.1016/j.ejca.2009.12.014
Cancer incidence and mortality in France over the period 1980???2005, Revue d'??pid??miologie et de Sant?? Publique, vol.56, issue.3, pp.159-75, 2008. ,
DOI : 10.1016/j.respe.2008.03.117
URL : https://hal.archives-ouvertes.fr/hal-00538673
Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non???Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.28, issue.13, pp.2191-2198, 2010. ,
DOI : 10.1200/JCO.2009.25.4052
Epidemiologic of primary bronchial carcinoma management in the general French hospital centers], Rev Mal Respir, vol.19, pp.727-761, 2002. ,
Cigarette Smoking and Changes in the Histopathology of Lung Cancer, JNCI Journal of the National Cancer Institute, vol.89, issue.21, pp.1580-1586, 1997. ,
DOI : 10.1093/jnci/89.21.1580
Les pathologies respiratoires li??es au tabagisme passif, Revue des Maladies Respiratoires, vol.26, issue.6, pp.667-78, 2009. ,
DOI : 10.1016/S0761-8425(09)74696-0
Lung cancer and passive smoking, Statistical Methods in Medical Research, vol.99, issue.2, pp.119-155, 1998. ,
DOI : 10.1177/096228029800700203
An Estimate of Cancers Attributable to Occupational Exposures in France, Journal of Occupational and Environmental Medicine, vol.52, issue.4, pp.399-406, 2010. ,
DOI : 10.1097/JOM.0b013e3181d5e355
URL : https://hal.archives-ouvertes.fr/hal-01260430
Epidemiology of asbestos-related diseases, Environmental Health Perspectives, vol.34, issue.11, pp.1-11, 1980. ,
DOI : 10.1289/ehp.80341
??pid??miologie du cancer bronchique primitif??: aspects classiques et nouveaut??s, Revue des Maladies Respiratoires, vol.28, issue.8, pp.1048-58, 2011. ,
DOI : 10.1016/j.rmr.2010.12.015
Cannabis Smoking and Risk of Lung Cancer in Men: A Pooled Analysis of Three Studies in Maghreb, Journal of Thoracic Oncology, vol.3, issue.12, pp.1398-403, 2008. ,
DOI : 10.1097/JTO.0b013e31818ddcde
URL : https://hal.archives-ouvertes.fr/hal-00428254
Cannabis use and cancer of the head and neck: Case-control study, Otolaryngology-Head and Neck Surgery, vol.74, issue.3, pp.374-80, 2008. ,
DOI : 10.1016/j.otohns.2007.12.002
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: International Multidisciplinary Classification of Lung Adenocarcinoma: Executive Summary, Proceedings of the American Thoracic Society, vol.8, issue.5, pp.381-386, 2011. ,
DOI : 10.1513/pats.201107-042ST
Structural and biological properties of a papillary component generating a micropapillary component in lung adenocarcinoma, Lung Cancer, vol.67, issue.3, pp.282-291, 2010. ,
DOI : 10.1016/j.lungcan.2009.04.014
True Papillary Carcinoma of the Lung, The American Journal of Surgical Pathology, vol.21, issue.1, pp.43-51, 1997. ,
DOI : 10.1097/00000478-199701000-00005
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma, Journal of Thoracic Oncology, vol.6, issue.2, pp.244-85, 2011. ,
DOI : 10.1097/JTO.0b013e318206a221
URL : https://hal.archives-ouvertes.fr/inserm-00561753
Mucinous Differentiation Correlates with Absence of EGFR Mutation and Presence of KRAS Mutation in Lung Adenocarcinomas with Bronchioloalveolar Features, The Journal of Molecular Diagnostics, vol.9, issue.3, pp.320-326, 2007. ,
DOI : 10.2353/jmoldx.2007.060182
Gene-Mutation Analyses for Japanese Lung Adenocarcinomas, American Journal of Clinical Pathology, vol.128, issue.1, pp.100-108, 2007. ,
DOI : 10.1309/WVXFGAFLAUX48DU6
Immunohistochemistry of pulmonary and pleural neoplasia, Arch Pathol Lab Med, vol.132, pp.1062-72, 2008. ,
The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain, Development, vol.113, issue.22, pp.1093-104, 1991. ,
The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis., Molecular and Cellular Biology, vol.14, issue.9, pp.5671-81, 1994. ,
DOI : 10.1128/MCB.14.9.5671
Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesothelioma, Human Pathology, vol.30, issue.6, pp.695-700, 1999. ,
DOI : 10.1016/S0046-8177(99)90096-5
New driver mutations in non-small-cell lung cancer, The Lancet Oncology, vol.12, issue.2, pp.175-80, 2011. ,
DOI : 10.1016/S1470-2045(10)70087-5
Frequency and prognostic evaluation of 3p21-22 allelic losses in non-small-cell lung cancer, International Journal of Cancer, vol.215, issue.6 ,
DOI : 10.1002/ijc.2910640604
Pulmonary preneoplasia - sequential molecular carcinogenetic events, Histopathology, vol.29, issue.1, pp.43-54, 2009. ,
DOI : 10.1111/j.1365-2559.2008.03182.x
URL : https://hal.archives-ouvertes.fr/inserm-00360878
Pathogenesis of lung cancer signalling pathways: roadmap for therapies, European Respiratory Journal, vol.33, issue.6, pp.1485-97, 2009. ,
DOI : 10.1183/09031936.00014009
K-ras Mutations in Non-Small-Cell Lung Carcinoma: A Review, Clinical Lung Cancer, vol.8, issue.1, pp.30-38, 2006. ,
DOI : 10.3816/CLC.2006.n.030
Key Signaling Pathways and Targets in Lung Cancer Therapy, Clinical Lung Cancer, vol.8, issue.30 2, pp.52-60, 2007. ,
DOI : 10.3816/CLC.2007.s.002
Molecular Analysis-Based Treatment Strategies for the Management of Non-small Cell Lung Cancer, Journal of Thoracic Oncology, vol.4, issue.9, pp.1029-1039, 2009. ,
DOI : 10.1097/JTO.0b013e3181b27170
Class IA Phosphatidylinositol 3-Kinase Signaling in Non-small Cell Lung Cancer, Journal of Thoracic Oncology, vol.4, issue.7, pp.787-91, 2009. ,
DOI : 10.1097/JTO.0b013e3181a74dba
Oncogenic Pathways, Molecularly Targeted Therapies, and Highlighted Clinical Trials in Non-Small-Cell Lung Cancer (NSCLC) Clin Lung Cancer, 2011. ,
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling, Science, vol.316, issue.5827, pp.1039-1082, 2007. ,
DOI : 10.1126/science.1141478
Identification of the transforming EML4???ALK fusion gene in non-small-cell lung cancer, Nature, vol.276, issue.7153, pp.561-567, 2007. ,
DOI : 10.1038/nature05945
TP53 Mutations in Nonsmall Cell Lung Cancer, Journal of Biomedicine and Biotechnology, vol.9, issue.3, p.583929, 2011. ,
DOI : 10.1038/nrd2656
p16INK4A inactivation mechanisms in non-small-cell lung cancer patients occupationally exposed to asbestos, Lung Cancer, vol.67, issue.1, pp.23-30, 2010. ,
DOI : 10.1016/j.lungcan.2009.03.018
URL : https://hal.archives-ouvertes.fr/inserm-00388198
Lung Cancer in Never Smokers: Molecular Profiles and Therapeutic Implications, Clinical Cancer Research, vol.15, issue.18, pp.5646-61, 2009. ,
DOI : 10.1158/1078-0432.CCR-09-0377
Molecular genetics of lung cancer in people who have never smoked, The Lancet Oncology, vol.9, issue.7, pp.676-82, 2008. ,
DOI : 10.1016/S1470-2045(08)70174-8
Anaplastic lymphoma kinase proteins in growth control and cancer, Journal of Cellular Physiology, vol.168, issue.3, pp.330-58, 2004. ,
DOI : 10.1002/jcp.10472
The anaplastic lymphoma kinase in the pathogenesis of cancer, Nature Reviews Cancer, vol.159, issue.1, pp.11-23, 2008. ,
DOI : 10.1002/ijc.21490
The emerging pathogenic and therapeutic importance of the anaplastic lymphoma kinase gene, European Journal of Cancer, vol.46, issue.13, pp.2357-68, 2010. ,
DOI : 10.1016/j.ejca.2010.04.006
Anaplastic lymphoma kinase in human cancer, Journal of Molecular Endocrinology, vol.47, issue.1, pp.11-23, 2011. ,
DOI : 10.1530/JME-11-0004
Targeting Oncogenic ALK: A Promising Strategy for Cancer Treatment, Molecular Cancer Therapeutics, vol.10, issue.4, pp.569-79, 2011. ,
DOI : 10.1158/1535-7163.MCT-10-0615
Inhibition of ALK Signaling for Cancer Therapy, Clinical Cancer Research, vol.15, issue.18, pp.5609-5623, 2009. ,
DOI : 10.1158/1078-0432.CCR-08-2762
Identification of the transforming EML4???ALK fusion gene in non-small-cell lung cancer, Nature, vol.276, issue.7153, pp.561-567, 2007. ,
DOI : 10.1038/nature05945
EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas, Lung Cancer, vol.61, issue.2, pp.163-172, 2008. ,
DOI : 10.1016/j.lungcan.2007.12.013
variant in nonsmall cell lung cancer, Cancer, vol.363, issue.12, pp.2709-2727, 2011. ,
DOI : 10.1002/cncr.25843
Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung Cancer, Cell, vol.131, issue.6, pp.1190-203, 2007. ,
DOI : 10.1016/j.cell.2007.11.025
KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer, Clinical Cancer Research, vol.15, issue.9, pp.3143-3152, 2009. ,
DOI : 10.1158/1078-0432.CCR-08-3248
Targeting Anaplastic Lymphoma Kinase in Lung Cancer, Clinical Cancer Research, vol.17, issue.8, pp.2081-2087, 2011. ,
DOI : 10.1158/1078-0432.CCR-10-1591
Evaluation of EML4-ALK Fusion Proteins in Non???Small Cell Lung Cancer Using Small Molecule Inhibitors, Neoplasia, vol.13, issue.1, pp.1-11, 2011. ,
DOI : 10.1593/neo.101120
Anaplastic Lymphoma Kinase Inhibition in Non???Small-Cell Lung Cancer, New England Journal of Medicine, vol.363, issue.18, pp.1693-703, 2010. ,
DOI : 10.1056/NEJMoa1006448
Worse Disease-Free Survival in Never-Smokers with ALK+ Lung Adenocarcinoma, Journal of Thoracic Oncology, vol.7, issue.1, pp.90-97, 2012. ,
DOI : 10.1097/JTO.0b013e31823c5c32
EML4-ALK Translocation Predicts Better Outcome in Lung Adenocarcinoma Patients with Wild-Type EGFR, Journal of Thoracic Oncology, vol.7, issue.1, pp.98-104, 2012. ,
DOI : 10.1097/JTO.0b013e3182370e30
Targeting Anaplastic Lymphoma Kinase in Lung Cancer, Clinical Cancer Research, vol.17, issue.8, pp.2081-2087, 2011. ,
DOI : 10.1158/1078-0432.CCR-10-1591
ALK Inhibition for Non-Small Cell Lung Cancer: From Discovery to Therapy in Record Time, Cancer Cell, vol.18, issue.6, pp.548-51, 2010. ,
DOI : 10.1016/j.ccr.2010.11.033
Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis, The Lancet Oncology, vol.12, issue.11, pp.1004-1016, 2011. ,
DOI : 10.1016/S1470-2045(11)70232-7
Correlations between the percentage of tumor cells showing an ALK (anaplastic lymphoma kinase) gene rearrangement, ALK signal copy number, and response to crizotinib therapy in ALK fluorescence in situ hybridization-positive nonsmall cell lung cancer, Cancer, 2012. ,
Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer A proposal of diagnostic algorithm for ALK-rearranged adenocarcinoma, Lung Cancer, issue.61, 2011. ,
EML4-ALK Rearrangement in Non-Small Cell Lung Cancer and Non-Tumor Lung Tissues, The American Journal of Pathology, vol.174, issue.2, pp.661-70, 2009. ,
DOI : 10.2353/ajpath.2009.080755
Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer A proposal of diagnostic algorithm for ALK-rearranged adenocarcinoma, Lung Cancer, issue.64, 2011. ,
Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged nonsmall cell lung cancer and beyond, Drug Design, Development and Therapy, vol.5, pp.471-85, 2011. ,
DOI : 10.2147/DDDT.S19045
Comprehensive Histologic Analysis of ALK-Rearranged Lung Carcinomas, The American Journal of Surgical Pathology, vol.35, issue.8, pp.1226-1260, 2011. ,
DOI : 10.1097/PAS.0b013e3182233e06
Signet ring cell adenocarcinoma of the lung with an EML4???ALK fusion gene mimicking mucinous (colloid) adenocarcinoma: A case report, Lung Cancer, vol.73, issue.3, pp.375-383, 2011. ,
DOI : 10.1016/j.lungcan.2011.05.016
EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset, Modern Pathology, vol.8, issue.4, pp.508-523, 2009. ,
DOI : 10.1158/0008-5472.CAN-06-4774
Frequent ALK rearrangement and TTF-1/p63 co-expression in lung adenocarcinoma with signet-ring cell component, Lung Cancer, vol.72, issue.3, pp.309-324, 2011. ,
DOI : 10.1016/j.lungcan.2010.09.013
The biology and treatment of EML4-ALK non-small cell lung cancer, European Journal of Cancer, vol.46, issue.10, pp.1773-80, 2010. ,
DOI : 10.1016/j.ejca.2010.04.002
Dual IHC and FISH Testing for ALK Gene Rearrangement in Lung Adenocarcinomas in a Routine Practice: A French Study, Journal of Thoracic Oncology, vol.7, issue.2, pp.348-54, 2012. ,
DOI : 10.1097/JTO.0b013e3182381535
Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer A proposal of diagnostic algorithm for ALK-rearranged adenocarcinoma, Lung Cancer, issue.72, 2011. ,
Screening of Anaplastic Lymphoma Kinase Rearrangement by Immunohistochemistry in Non-small Cell Lung Cancer: Correlation with Fluorescence In Situ Hybridization, Journal of Thoracic Oncology, vol.6, issue.3, pp.466-72, 2011. ,
DOI : 10.1097/JTO.0b013e31820b82e8
A Novel, Highly Sensitive Antibody Allows for the Routine Detection of ALK-Rearranged Lung Adenocarcinomas by Standard Immunohistochemistry, Clinical Cancer Research, vol.16, issue.5, pp.1561-71, 2010. ,
DOI : 10.1158/1078-0432.CCR-09-2845
Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged nonsmall cell lung cancer and beyond, Drug Design, Development and Therapy, vol.5, issue.75, pp.471-85, 2011. ,
DOI : 10.2147/DDDT.S19045
Histologic subtypes, immunohistochemistry, FISH or molecular screening for the accurate diagnosis of ALKrearrangement in lung cancer: A comprehensive study of Caucasian non-smokers, Lung Cancer, issue.76, 2011. ,
Correlations between the percentage of tumor cells showing an ALK (anaplastic lymphoma kinase) gene rearrangement, ALK signal copy number, and response to crizotinib therapy in ALK fluorescence in situ hybridization-positive nonsmall cell lung cancer, Cancer, 2012. ,
Screening of Anaplastic Lymphoma Kinase Rearrangement by Immunohistochemistry in Non-small Cell Lung Cancer: Correlation with Fluorescence In Situ Hybridization, Journal of Thoracic Oncology, vol.6, issue.3, pp.466-72, 2011. ,
DOI : 10.1097/JTO.0b013e31820b82e8
Correlation of IHC and FISH for ALK Gene Rearrangement in Non-small Cell Lung Carcinoma: IHC Score Algorithm for FISH, Journal of Thoracic Oncology, vol.6, issue.3, pp.459-65, 2011. ,
DOI : 10.1097/JTO.0b013e318209edb9
Screening of Anaplastic Lymphoma Kinase Rearrangement by Immunohistochemistry in Non-small Cell Lung Cancer: Correlation with Fluorescence In Situ Hybridization, Journal of Thoracic Oncology, vol.6, issue.3, pp.466-72, 2011. ,
DOI : 10.1097/JTO.0b013e31820b82e8
(DeltaNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma, Mod Pathol, vol.25, issue.81, pp.40405-40420, 2012. ,
Evaluation of Napsin A, Cytokeratin 5/6, p63, and Thyroid Transcription Factor 1 in Adenocarcinoma Versus Squamous Cell Carcinoma of the Lung, Archives of Pathology & Laboratory Medicine, vol.136, issue.2, pp.155-62, 2012. ,
DOI : 10.5858/arpa.2011-0232-OA